Long-Term Clinical Outcomes of Sirolimus- Versus Paclitaxel-Eluting Stents for Patients With Unprotected Left Main Coronary Artery DiseaseAnalysis of the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) Registry
Jong-Young Lee, MD*,
Duk-Woo Park, MD, PhD*,
Sung-Cheol Yun, PhD ,
Seung-Whan Lee, MD, PhD*,
Young-Hak Kim, MD, PhD*,
Cheol Whan Lee, MD, PhD*,
Myeong-Ki Hong, MD, PhD*,
Seong-Wook Park, MD, PhD* and
Seung-Jung Park, MD, PhD*,*
* Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Division of Biostatistics, Center for Medical Research and Information, University of Ulsan College of Medicine, Seoul, Korea

View larger version (18K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Kaplan-Meier Curves of the Primary Composite End Point (Death, MI, TVR) and Each Component Between SES abd PES
MI = myocardial infarction; PES = paclitaxel-eluting stent(s); SES = sirolimus-eluting stent(s); TVR = target vessel revascularization.
|
|
|